These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 5090761)

  • 21. Clinical use of potassium supplements and potassium sparing diuretics.
    Morgan TO
    Drugs; 1973; 6(3):222-9. PubMed ID: 4778987
    [No Abstract]   [Full Text] [Related]  

  • 22. How to treat arterial hypertension.
    Finnerty FA
    Am Fam Physician; 1973 Apr; 7(4):99-108. PubMed ID: 4694341
    [No Abstract]   [Full Text] [Related]  

  • 23. Biochemical changes in black and Indian hypertensive patients on diuretic therapy.
    Bhigjee AI; Seedat YK; Hoosen S; Neerahoo RM; Naidoo K
    S Afr Med J; 1983 Dec; 64(25):969-72. PubMed ID: 6648735
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Double-blind crossover study of fenquizone compared to chlorthalidone in essential hypertension.
    Angelino PF; Alvino-Demartino A; Mappa R; Donati C
    Int J Clin Pharmacol Ther Toxicol; 1985 Sep; 23(9):501-5. PubMed ID: 3902676
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Outpatient conversion of treatment to potassium-sparing diuretics.
    Ridgeway NA; Ginn DR; Alley K
    Am J Med; 1986 May; 80(5):785-8. PubMed ID: 3706365
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical use of the potassium-sparing diuretics.
    Krishna GG; Shulman MD; Narins RG
    Semin Nephrol; 1988 Dec; 8(4):354-64. PubMed ID: 3068756
    [No Abstract]   [Full Text] [Related]  

  • 27. Maximizing diuretic therapy in resistant hypertension.
    Handler J
    J Clin Hypertens (Greenwich); 2007 Oct; 9(10):802-6. PubMed ID: 17917510
    [No Abstract]   [Full Text] [Related]  

  • 28. Treatment of mild-to-moderate hypertension: comparison between a calcium-channel blocker and a potassium-sparing diuretic.
    Boulet AP; Chockalingam A; Fodor JG; Laplante L; Houde M; Lenis J; Logan AG; Robitaille MN; Ryan D; Spénard J
    J Cardiovasc Pharmacol; 1991; 18 Suppl 9():S45-50. PubMed ID: 1725543
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Diuretics. Clinical pharmacology and therapeutic use (Part II).
    Lant A
    Drugs; 1985 Feb; 29(2):162-88. PubMed ID: 3884320
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of two combined diuretics in the treatment of essential hypertension.
    Verhiest W; Baehre M; Volkers P
    Int J Clin Pharmacol Ther Toxicol; 1989 Jul; 27(7):342-5. PubMed ID: 2674028
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Serum cholesterol during treatment of hypertension with diuretic drugs.
    Ames RP; Peacock PB
    Arch Intern Med; 1984 Apr; 144(4):710-4. PubMed ID: 6712367
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical evaluation of amiloride, a potassium-sparing diuretic.
    Lant AF; Smith AJ; Wilson GM
    Clin Pharmacol Ther; 1969; 10(1):50-63. PubMed ID: 4884296
    [No Abstract]   [Full Text] [Related]  

  • 33. [Correlations between blood pressure, blood volume and plasma renin during therapy with diuretics in essential hypertension. Comparison between the mineralocorticoid antagonist spironolactone and the "loop" diuretic mefruside].
    Beretta-Piccoli C; Weidmann P; de Châtel R; Hirsch D; Reubi FC
    Schweiz Med Wochenschr; 1977 Jan; 107(4):104-15. PubMed ID: 834983
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Diuretics and cholesteremia: effects of short and long term diuretic treatment in senile subjects].
    Scotti G
    Acta Gerontol (Milano); 1969; 19(4):216-25. PubMed ID: 5405811
    [No Abstract]   [Full Text] [Related]  

  • 35. [Objectives and methods in therapy of essential arterial hypertension].
    Zanchetti A
    Cardiol Prat; 1968 Aug; 19(4):263-6. PubMed ID: 5746811
    [No Abstract]   [Full Text] [Related]  

  • 36. Kalemia during combined therapy with an angiotensin converting enzyme inhibitor and a potassium-sparing diuretic.
    Mooser V; Waeber G; Bidiville J; Waeber B; Nussberger J; Brunner HR
    J Clin Hypertens; 1987 Dec; 3(4):510-3. PubMed ID: 2839627
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of chlorthalidone on serum and total body potassium in hypertensive patients.
    Leemhuis MP; van Damme KJ; Struyvenberg A
    Acta Med Scand; 1976; 200(1-2):37-45. PubMed ID: 8958
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Diuretics and hypokalaemia: aldosterone antagonists or potassium supplementation?
    Demanet JC
    Acta Clin Belg; 1974; 29(3):176-8. PubMed ID: 4842207
    [No Abstract]   [Full Text] [Related]  

  • 39. [Properties and indications of potassium-sparing diuretics].
    Rorive G; Krzesinski JM
    Rev Med Liege; 1986 May; 41(9):330-6. PubMed ID: 3523669
    [No Abstract]   [Full Text] [Related]  

  • 40. Effects of spironolactone on serum and muscle electrolytes in patients on long-term diuretic therapy for congestive heart failure and/or arterial hypertension.
    Dyckner T; Wester PO; Widman L
    Eur J Clin Pharmacol; 1986; 30(5):535-40. PubMed ID: 3758141
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.